Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.

ABSTRACT:

Background

Lymph node metastasis (LNM) is an important factor affecting endometrial cancer (EC) prognosis. Current controversy exists as to how to accurately assess the risk of lymphatic metastasis. Metabolic syndrome has been considered a risk factor for endometrial cancer, yet its effect on LNM remains elusive. We developed a nomogram integrating metabolic syndrome indicators with other crucial variables to predict lymph node metastasis in endometrial cancer.

Methods

This study is based on patients diagnosed with EC in Peking University People's Hospital between January 2004 and December 2020. A total of 1076 patients diagnosed with EC and who underwent staging surgery were divided into training and validation cohorts according to the ratio of 2:1. Univariate and multivari

SUBMITTER: Feng X 

PROVIDER: S-EPMC10318658 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature